Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-03T01:17:42.423Z Has data issue: false hasContentIssue false

The pyogenic potential of the different Streptococcus anginosus group bacterial species: retrospective cohort study

Published online by Cambridge University Press:  14 August 2017

O. KOBO*
Affiliation:
Department of Internal Medicine C, Rambam Health Care Campus, Haifa, Israel
S. NIKOLA
Affiliation:
The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel
Y. GEFFEN
Affiliation:
The Microbiology Laboratory, Rambam Health Care Campus, Haifa, Israel
M. PAUL
Affiliation:
The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel Infectious Diseases Institute, Rambam Health Care Campus, Haifa, Israel
*
*Author for correspondence: O. Kobo, Department of Internal Medicine C, Rambam Health Care Campus, HaAliya HaShniya St 8, POB 9602, Haifa 31096, Israel. (Email: [email protected])
Rights & Permissions [Opens in a new window]

Summary

Streptococcus anginosus Group (SAG) bacteria are common causes of pyogenic infections (PIs). We examined the association between SAG species and the presence of a PI through a retrospective, observational, cohort study, between the years 2009 and 2015. All adults with clinically significant SAG infections in one hospital in Israel were assessed for association between SAG species and the presence of a PI defined as an abscess, empyema, or deep/organ space surgical site infection. Risk factors for PI were assessed using multivariate backward stepwise logistic regression analysis. We identified 263 patients with significant SAG infections, 182 (69%) of which were caused by S. anginosus, 45 (17·1%) by Streptococcus constellatus and 36 (13·7%) by Streptococcus intermedius. The mean age of the patients was 56·8 ± 19·1 years. PIs were identified among 160 (60%) of the patients and were mostly non-bacteraemic (147/160, 91·8%), while most non-PI patients had bacteraemia (70/103, 68%). S. anginosus and S. constellatus were associated with a significantly lower incidence of PI than S. intermedius, OR 0·18 (95% CI 0·06–0·53) and 0·14 (0·04–0·48), respectively. Patients with PI were younger and, in general, had less co-morbidities. S. intermedius was associated with pyogenic non-bacteraemic infections, while S. anginosus and S. constellatus were associated with bacteraemia with no abscess or empyema formation. These data may indicate differences in virulence mechanisms of these SAG bacteria.

Type
Short Report
Copyright
Copyright © Cambridge University Press 2017 

Streptococcus anginosus Group (SAG) infections are the most common streptococcal species causing pyogenic infections (PIs) and have variable clinical manifestations [Reference Laupland1, Reference Gossling2]. Few data are available on the differences in clinical virulence of the different SAG species (S. anginosus, Streptococcus intermedius and Streptococcus constellatus) and their differential ability to cause a PI. In one retrospective cohort, 35% of 245 SAG infections presented as a PI infection, with no reported differences between the species [Reference Siegman-Igra, Azmon and Schwartz3]. In another retrospective study of 118 patients with SAG infection, the proportion of patients with abscesses was 51% and S. anginosus was associated less frequently with abscess formation than the other SAG species [Reference Claridge4]. S. intermedius has been linked to a worse prognosis, longer hospital stay [Reference Junckerstorff, Robinson and Murray5] and disseminated PI [Reference Simone6]. However, these studies did not adjust for underlying clinical characteristics of patients infected with different SAG species.

Our objective was to examine retrospectively the association between SAG species and the presence of a PI in a relatively large cohort of patients over a 7-year period.

A retrospective, observational, cohort study was performed at Rambam Health Care Campus (RHCC) between the years 2009 and 2015. RHCC is a primary and tertiary care university-affiliated hospital of 960 beds, in northern Israel. The study was approved by the hospital's ethics committee with a waiver of informed consent given the observational nature of the study.

We included all consecutive adults (>18 years) with clinically significant SAG infection. Patients were identified by the microbiology laboratory reports of all SAG isolates from all sites. From these, all patients fulfilling Systemic Inflammatory Response Syndrome criteria [Reference Bone7] accompanied by symptoms or signs of infection at the site of isolation or blood cultures positive for SAG were included. The dependent variable was the presence of a PI, defined as a deep tissue abscess, empyema, joint or bone infection or a surgical site infection (SSI) involving the operated organ or bone (organ/space SSI [Reference Horan, Andrus and Dudeck8]) from which SAG was isolated (thereafter termed ‘PI’). Other outcomes included disseminated infection, defined as a PI involving two or more organs, length of hospital stay, all-cause 30-day and in-hospital mortality. The exposure variable was the species of SAG; S. anginosus, S. intermedius or S. constellatus. We collected a large dataset of potential predictors for PIs including patients’ demographics, background conditions, place of infection acquisition, infection presentation and presence of polymicrobial infection.

Data were collected from patients’ medical records. RHCC operates a full electronic patient file that includes all clinical, laboratory and radiological data in the study years. Mortality data are updated by the national registry of the Ministry of Health.

SAG were identified to the species level using the Vitek 2 system (bioMerieux, Marcy l'Etoile, France).

We targeted a sample of at least 140 patients, assuming a 50% rate of PIs to include five independent variables in a multivariate analysis in addition to the exposure variable and compared between patients with and without pyogenic SAG infection. Categorical variables were compared using the χ 2 test or the Fisher exact test, and continuous variables were compared using the t test or the Mann–Whitney U-test, as appropriate. Variables found significant on univariate analysis (P < 0·05) were examined for statistical and clinical correlations and non-correlated variables were entered into a multivariate backward stepwise logistic regression analysis, in which the dependent variable was pyogenic infection. SAG species was forced into the analysis multiple imputations of blood urea nitrogen (BUN) were used for 19 patients to allow its inclusion in the regression model. Variables not contributing to the model's predictive ability were excluded from the final model. The goodness of fit and predictive ability of the model were examined using the Hosmer–Lemeshow and the receiver operating characteristics (ROC) curve, respectively. Analyses were performed using SPSS 20.

Over the study period, SAG bacteria were isolated from 301 adult patients, of which 263 had clinically significant infections, caused by S. anginosus in 182 patients (69·2%), S. constellatus in 45 (17·1%) and S. intermedius in 36 (13·7%). Male predominance was noted (168/263, 63·9%). The mean age of the patients was 56·8 ± 19·1 years. All-cause 30-day and in-hospital mortality rates were 45/263 (17·1%) and 39/263 (14·8%), respectively.

PIs were identified among 160/263 (60%) patients, and among these, 13 (8·1%) had bacteraemia and eight (5%) had disseminated infection. PIs included intra-abdominal abscesses or peritonitis (69 patients, 43·1%), skin/soft-tissue abscesses, arthritis or osteomyelitis (44 patients, 28·1%), empyema or lung abscesses (32 patients including one with both empyema and intra-abdominal infection, 20%) and intra-cranial abscesses (15 patients, 9·4%). Most patients with non-pyogenic infections had bacteraemia (70, 68%); none had endocarditis. Patients with PIs were generally younger and had fewer co-morbidities (Table 1). Most infections were acquired in the community, similarly in both groups. Surgical procedures were performed for abscess or empyema drainage in most patients with PI (141/160, 88·1%). Infection severity and mortality were higher in patients with non-pyogenic infections.

Table 1. Patient characteristics and outcomes of patients with pyogenic vs. non-pyogenic SAG infection

PIs were observed most commonly with S. intermedius (31/36, 86·1%) compared with 57·1% (104/182) with S. anginosus and 55·6% (25/45) with S. contellatus, P = 0·04. The final multivariate model predicting PIs included age, baseline cognitive or functional impairment, acute mental alternation and raised BUN at infection presentation and SAG species. Congestive heart failure, diabetes and other laboratory values failed to improve the model. S. anginosus (OR 0·18, 95% CI 0·06–0·53) and S. constellatus (OR 0·14, 95% CI 0·04–0·48) were associated with significantly fewer PIs compared with S. intermedius; age was the only other significant factor associated with PIs (Table 2). The model performance was adequate; Hosmer–Lemeshow P = 0·82, area under the ROC curve 0·74 (95% CI 0·67–0·8).

Table 2. Risk factors for pyogenic infection, multivariate analysis

a Measured at onset of infection.

Over the course of 7 years, we identified 263 patients with clinically significant SAG infections with S. anginosus being the most frequent species (69%) isolated. Overall, there was a relatively high proportion of PIs (60%) and these were associated with younger and healthier patients without bacteraemia, while bacteraemia occurred more frequently in patients without a PI. S. intermedius caused significantly more PIs than other SAG species, when adjusted to other differences between patients with and without pyogenic infections. Younger age remained significantly associated with PIs in the adjusted analysis. Survival was higher for patients with PIs, relating to the lower rate of bacteraemia in this group, younger age, fewer co-morbidities and possibly because drainage was performed in most of patients.

In agreement with our study, there is an evolving understanding that S. intermedius is more invasive and causes more severe infections than the other SAG species. In a literature review of 12 patients with SAG-disseminated infections (defined as involving two or more major organs), S. intermedius was responsible for six infections, while S. anginosus and S. constellatus caused two each [Reference Simone6]. Likewise, a retrospective single-centre study including 118 patients with SAG infections, S. intermedius was the least common but resulted in the highest rate of abscess formation (10/12, 88% of patients), compared with 41/54 (76%) with S. constellatus and 10/52 (19%) with S. anginosus, and a higher rate of bacteraemia [Reference Claridge4]. In our study, S. intermedius was similarly associated with a higher rate of PIs (using a broader definition than abscesses), but was associated with highly significantly lower rates of bacteraemia than S. constellatus and S. anginosus.

The reasons for the increased pyogenic potential of S. intermedius have not been fully elucidated. Genetic mutations resulting in overproduction of intermedilysin, a major virulence factor of SAG, has been described [Reference Tomoyasu9], while the presence and activity of hydrolytic enzymes (deoxyribonuclease and chondroitin sulfatase) have been reported to be present more frequently S. intermedius and S. constellatus, and were associated with infection-related strains [Reference Jacobs and Stobberingh10].

Our study, as most of the reviewed literature, is a retrospective single-centre study with its inherent limitations. The high proportion of PIs reported here may be explained by the fact that we included only clinically significant infections, unlike other studies with lower rates (35–51%) of such infections [Reference Siegman-Igra, Azmon and Schwartz3, Reference Claridge4]. We also employed a broader definition for ‘pyogenic infections’ and the long time span of the study enabled the collection of a relatively large series of patients, therefore allowing us to adjust for confounders when assessing the relative contribution of the individual SAG species to PIs. Throughout this period, the Vitek 2 system was used to identify the SAG isolates to the species level. Although currently molecular identification might be considered more accurate, several studies have confirmed the good performance of Vitek-2 in SAG identification [Reference Siegman-Igra, Azmon and Schwartz3, Reference Chatzigeorgiou11Reference Funke and Funke-Kissling13].

In conclusion, our findings suggest that compared with other SAG species, S. intermedius has the highest potential to cause infections involving abscess formation or other deep-seated infections and its identification should trigger an investigation to identify foci requiring surgical interventions. S. constellatus and S. anginosus caused bacteraemia without an associated pyogenic infection more frequently than S. intermedius.

ACKNOWLEDGEMENTS

The authors would like to acknowledge the contribution of the ESCMID Study Group for Infections in the Elderly (ESGIE) for the inspiration and motivation to conduct the study. The study was performed without funding.

DECLARATION OF INTEREST

None.

References

REFERENCES

1. Laupland, KB, et al. Population-based surveillance of invasive pyogenic streptococcal infection in a large Canadian region. Clinical Microbiology and Infection 2006; 12: 224230.Google Scholar
2. Gossling, J. Occurrence and pathogenicity of the Streptococcus milleri group. Reviews of infectious Diseases 1988; 10: 257285.Google Scholar
3. Siegman-Igra, Y, Azmon, Y, Schwartz, D. Milleri group streptococcus – a stepchild in the viridans family. European Journal of Clinical Microbiology & Infectious Diseases 2012; 31: 24532459.CrossRefGoogle ScholarPubMed
4. Claridge, JE, et al. Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (‘Streptococcus milleri group’) are of different clinical importance and are not equally associated with abscess. Clinical Infectious Diseases 2001; 32: 15111515.CrossRefGoogle Scholar
5. Junckerstorff, RK, Robinson, JO, Murray, RJ. Invasive Streptococcus anginosus group infection-does the species predict the outcome? International Journal of Infectious Diseases 2014; 18: 3840.Google Scholar
6. Simone, G, et al. Streptococcus anginosus group disseminated infection: case report and literature review. Le Infezioni in Medicina 2012; 3: 145154.Google Scholar
7. Bone, RC, et al. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Critical Care Medicine 1992; 20: 864874.Google Scholar
8. Horan, TC, Andrus, M, Dudeck, MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. American Journal of Infection Control 2008; 36: 309332. doi: 10.1016/j.ajic.2008.03.002.Google Scholar
9. Tomoyasu, T, et al. Lacr mutations are frequently observed in Streptococcus intermedius and are responsible for increased intermedilysin production and virulence. Infection and Immunity 2013; 81: 32763286.CrossRefGoogle ScholarPubMed
10. Jacobs, JA, Stobberingh, EE. Hydrolytic enzymes of Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius in relation to infection. European Journal of Clinical Microbiology & Infectious Diseases 1995; 14: 818820.Google Scholar
11. Chatzigeorgiou, KS, et al. Phoenix 100 versus Vitek 2 in the identification of Gram-positive and Gram-negative bacteria: a comprehensive meta-analysis. Journal of Clinical Microbiology 2011; 49: 32843291.Google Scholar
12. Haanpera, M, et al. Identification of alpha-hemolytic streptococci by pyrosequencing the 16S rRNA gene and by use of VITEK 2. Journal of Clinical Microbiology 2007; 45: 762770.Google Scholar
13. Funke, G, Funke-Kissling, P. Performance of the new VITEK 2 GP card for identification of medically relevant Gram-positive cocci in a routine clinical laboratory. Journal of Clinical Microbiology 2005; 43: 8488.Google Scholar
Figure 0

Table 1. Patient characteristics and outcomes of patients with pyogenic vs. non-pyogenic SAG infection

Figure 1

Table 2. Risk factors for pyogenic infection, multivariate analysis